Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
01/10/2013 | US20130011451 Footbed with non-denatured collagen |
01/10/2013 | US20130011448 System for improved delivery of gene modulating compounds |
01/10/2013 | US20130011385 Transparent bacterial cellulose nanocomposite hydrogels |
01/10/2013 | US20130011370 Uniform Field Magnetization and Targeting of Therapeutic Formulations |
01/10/2013 | US20130011363 Cationic betaine precursors to zwitterionic betaines having controlled biological properties |
01/10/2013 | US20130011347 Personal Care Compositions With Improved Solubility of a Solid Cosmetic Active |
01/10/2013 | US20130011342 Surfactant-free, water-free formable composition and breakable foams and their uses |
01/10/2013 | CA2843854A1 Herpes virus vaccine and methods of use |
01/10/2013 | CA2841079A1 Oral delivery of enzymes by nanocapsules for targeted metabolism of alcohol or toxic metabolites |
01/10/2013 | CA2840983A1 Adhesive skin patch containing serotonin receptor antagonist drug |
01/10/2013 | CA2840965A1 Cationic oil-in-water emulsions |
01/10/2013 | CA2840907A1 Cannabinoid receptor binding agents, compositions and methods |
01/10/2013 | CA2840876A1 Formulations that stabilize proteins |
01/10/2013 | CA2840711A1 Arginine-free tnfr:fc-fusion polypeptide compositions and methods of use |
01/10/2013 | CA2840221A1 P97-antibody conjugates and methods of use |
01/10/2013 | CA2839584A1 Pyrroloquinolinyl-pyrrolidine-2,5-dione formulations and methods for preparing and using same |
01/10/2013 | CA2839350A1 The use of serotonin receptor agonists for treatment of movement disorders |
01/10/2013 | CA2835232A1 A complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof |
01/09/2013 | EP2543387A1 Mucosal vaccine |
01/09/2013 | EP2543374A2 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
01/09/2013 | EP2543366A1 Film preparation containing medicament with unpleasant taste |
01/09/2013 | EP2543359A1 Gel for use in wound treatment |
01/09/2013 | EP2543357A1 Composition for use in treating and preventing inflammation related disorder |
01/09/2013 | EP2543340A1 Novel hydrophilic polymers as medical lubricants and gels |
01/09/2013 | EP2543263A1 High-potency sweetener composition with antioxidant and compositions sweetened therewith |
01/09/2013 | EP2542613A1 Derivatized hyperbranched polyglycerols |
01/09/2013 | EP2542265A2 Guanidinylated aminoglycoside -lipid conjugates |
01/09/2013 | EP2542264A1 Magnetic nanoparticles for cancer diagnostic and treatment purposes |
01/09/2013 | EP2542230A2 Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1 |
01/09/2013 | EP2542223A2 Complex formulation for oral administration comprising probiotic formulation and 5-ht4 receptor agonist and method for the preparation thereof |
01/09/2013 | EP2542222A2 Melt-coated pharmaceutical forms |
01/09/2013 | EP2542221A2 Concentrated protein formulations and uses thereof |
01/09/2013 | EP2542203A1 Surface immobilized chaperones |
01/09/2013 | CN1972668B Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
01/09/2013 | CN1935120B Effervescent dry-mixed suspension agent |
01/09/2013 | CN1876657B Stabilization of macrolides |
01/09/2013 | CN1642570B Stable pharmaceutical composition containing factor viii |
01/09/2013 | CN102869774A Compositions for targeted delivery of sirna |
01/09/2013 | CN102869679A Stable MIA/CD-RAP formulation |
01/09/2013 | CN102869384A Methods and compositions using peptides and proteins with C-terminal elements |
01/09/2013 | CN102869383A DNA dendrimers as thermal ablation devices |
01/09/2013 | CN102869371A An insulin conjugate using an immunoglobulin fragment |
01/09/2013 | CN102869362A Vitamin-containing nutrition infusion for administration through peripheral vein |
01/09/2013 | CN102869347A Spray-pumpable composition suitable for topical skin application |
01/09/2013 | CN102869345A Pharmaceutical composition for treatment of increased intraocular pressure |
01/09/2013 | CN102869342A Clay compositions |
01/09/2013 | CN102863630A Novel physical hydrogel and usage thereof |
01/09/2013 | CN102863627A Cisplatin complex and preparation method thereof |
01/09/2013 | CN102863557A Preparation method and application of fatty acid-trimethyl chitosan polymer modified by lactobionic acid |
01/09/2013 | CN102863556A Lactose acidized glycyrrhetinic chitosan material and preparation method and application thereof |
01/09/2013 | CN102863538A Fused polypeptide mutant containing protein transduction domain and preparation method thereof |
01/09/2013 | CN102863537A Tumor targeting tumor necrosis factor related apoptosis ligand variant and application thereof |
01/09/2013 | CN102863532A Interferon alpha receptor 1 antibodies and their uses |
01/09/2013 | CN102863349A Flavor-enhancing amide compounds |
01/09/2013 | CN102863026A Water-dispersible manganese-doped magnetic nano-cluster, and preparation method and application thereof |
01/09/2013 | CN102861374A Pessulum capable of steadily releasing medicine |
01/09/2013 | CN102861360A Neural restoration promoting material as well as preparation method and application thereof |
01/09/2013 | CN102861342A Scutellarin prodrug using cyclodextrin as carrier and preparation method for scutellarin prodrug |
01/09/2013 | CN102861341A Composite nano-carrier capable of loading nucleic acid drugs efficiently and preparation method of composite nano-carrier |
01/09/2013 | CN102861340A Intelligent nano delivery system, preparation method and application thereof |
01/09/2013 | CN102861339A Pharmaceutical composition for aerosols with two or more active substances and at least one surfactant |
01/09/2013 | CN102861337A Egualen sodium containing solid preparation |
01/09/2013 | CN102861334A Tumor signal response active treating nano photodynamic drug carrier and preparation method thereof |
01/09/2013 | CN102861331A CD (cluster differentiation) 146 and application thereof to antibody diagnosis and treatment for inflammable diseases such as autoimmunity diseases |
01/09/2013 | CN102861330A Haemophilus influenzae type b (Hib) polysaccharide and refined tetanus toxoid coupling process |
01/09/2013 | CN102861326A Epidemic encephalitis polysaccharide-protein conjugated vaccine and preparation method thereof |
01/09/2013 | CN102861322A Hemoglobin-based oxygen carrier and preparation method thereof |
01/09/2013 | CN102861153A Local anesthetic |
01/09/2013 | CN102861040A Medicine composition containing aspirin, acetaminophen and caffeine and preparation method thereof |
01/09/2013 | CN102861018A Pitavastatin calcium preparation and preparation technology |
01/09/2013 | CN102861014A Worm-disease-resisting compound niclosamide tablet for beasts and birds and preparation method thereof |
01/09/2013 | CN102861013A Pharmaceutical composition and preparation of 17 amino acids |
01/09/2013 | CN102861012A Medicine composition containing 18 amino acids and preparation thereof |
01/09/2013 | CN102861011A Medicine composition of 18 amino acids and preparation |
01/09/2013 | CN102861010A Imidafenacin pharmaceutical composition with improved oral-taking absorbency |
01/09/2013 | CN102860997A Ondansetron oral cavity instant membrane capable of sheltering taste and preparation method thereof |
01/09/2013 | CN102860995A Enrofloxacin effervescent granule for livestock and preparation method thereof |
01/09/2013 | CN102860991A Medicine composition containing febuxostat and preparation method thereof |
01/09/2013 | CN102860990A Cefetamet pivoxil hydrochloride dispersible tablet and preparation method thereof |
01/09/2013 | CN102860989A Two formulations of chiral drug R/S (+/-)-1-[4-(2-methoxyphenyl) piperazinyl]-3-(1-naphthyloxyl)-2-propanol optical isomer |
01/09/2013 | CN102860988A Chymotrypsin composition freeze-dried powder and preparation method thereof |
01/09/2013 | CN102860986A Stable taste-masking levocetirizine medicine composition and preparation method thereof |
01/09/2013 | CN102860985A Tebipenem pivoxil oral preparation and preparation method thereof |
01/09/2013 | CN102860983A Novel pharmaceutical composition of 2-(4- isobutylphenyl) propionic acid |
01/09/2013 | CN102860982A Tilianin microemulsion composition |
01/09/2013 | CN102860981A Schistosomiasis resistant praziquantel transdermal solution for flocks and herds and preparation method |
01/09/2013 | CN102512359B Mangiferin cream with anti-herpes virus effect |
01/09/2013 | CN102406945B Fluorocarbon and cyclodextrin inclusion compound and preparation method thereof |
01/09/2013 | CN102379883B Pharmaceutical composition of glycerin fructose injection |
01/09/2013 | CN102343100B Method for quickly preparing rutin inclusion compound |
01/09/2013 | CN102342937B Amlodipine and candesartan pharmaceutical composition and preparation method thereof |
01/09/2013 | CN102335626B Method for synthesizing micro/nano zeolitic imidazolate frameworks (ZIFs) |
01/09/2013 | CN102266311B Compound membrane for treating canker sore and preparation method of compound membrane |
01/09/2013 | CN102258786B Porous microspheres for medicine carriers, preparation method and medicine loading method |
01/09/2013 | CN102258642B Formulas of Chinese medicinal external washing powder and effervescent tablets for treating traumatic injury and preparation methods thereof |
01/09/2013 | CN102258497B Lamivudine tablet composition and preparation method thereof |
01/09/2013 | CN102247318B Oxytetracycline uterus injectant and preparation method thereof |
01/09/2013 | CN102139112B Drug carrier material and preparation method and application thereof |
01/09/2013 | CN102138904B Self-solidified microspheres and preparation method and application thereof |
01/09/2013 | CN102106841B Tamsulosin hydrochloride preparation and preparation method thereof |